Catalyst Wire Dossier Catalyst Wire Dossier
CLINICAL_TRIALS trial_result · 2017-05-19

Clinical Trial Update: Bevacizumab and Radiation Therapy for Sarcomas [Phase 2]

View source ↗

Summary

Phase 2 trial evaluating bevacizumab with radiation therapy in soft tissue sarcomas completed, with results posted in 2017.

Upgrade for the full analysis, importance score, and drug timeline.

Diseases / indications

Drugs mentioned

  • Avastin (bevacizumab)

Snippet

Sponsor: Massachusetts General Hospital | Conditions: Soft Tissue Sarcoma, Fibrous Histiocytoma | Phase 2 | Status: COMPLETED | Results posted: 2017-05-19